01866nam 2200433Ia 450 991069880740332120090604163702.0(CKB)5470000002397796(OCoLC)370471736(EXLCZ)99547000000239779620090604d2009 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps)Rockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2009]i, 14 pages digital, PDF fileTitle from PDF title page (viewed on June 4, 2009)."Draft guidance"."March 2009".Includes bibliographical references (p. 12-14).Guidance for industry Trypanosoma cruziUnited StatesPreventionBloodTransfusionGovernment policyUnited StatesCell transplantationGovernment policyUnited StatesTransplantation of organs, tissues, etcGovernment policyUnited StatesTrypanosoma cruziPrevention.BloodTransfusionGovernment policyCell transplantationGovernment policyTransplantation of organs, tissues, etc.Government policyCenter for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698807403321Guidance for industry3434577UNINA